0.74
-0.56(-43.08%)
Currency In USD
Address
149 Fifth Avenue
New York City, NY 10010
United States of America
Phone
212 994 8200
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
April 27, 2021
| Name | Title | Pay | Year Born |
| Alexander Kenneth Arrow | Chief Financial Officer & Secretary | 150,000 | 1971 |
| Andrew Slee | Chief Operating Officer | 0 | 1950 |
| Garo H. Armen | Co-Founder & Executive Chairman of the Board | 0 | 1953 |
| Robert Benjamin Stein | Chief Medical Officer & Director | 0 | 1951 |
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.